NONOF

Novo Nordisk (PK) (NONOF)

Novo Nordisk (PK)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:NONOF

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/10	22:32	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/06/04	00:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/28	19:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/18	05:33	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/18	00:30	Edgar (US Regulatory)	Form SD - Specialized disclosure report	USOTC:NONOF	Novo Nordisk (PK)
2024/05/15	21:57	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/07	06:13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/07	06:12	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/07	06:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/05/06	19:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/22	20:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/22	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/14	22:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/14	04:24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/12	23:18	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/09	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/07	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/07	05:14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/06	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/05	20:57	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/02/02	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/01/12	00:34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/01/08	22:38	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2024/01/08	22:19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2023/12/20	00:51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2023/11/28	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2023/11/13	20:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2023/11/07	06:39	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2023/11/07	06:39	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)
2023/11/04	00:35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NONOF	Novo Nordisk (PK)